Keros Therapeutics’ Post

Is anyone really watching your #heathcare systems that truly understand your workflow? I'll bet you dinner that they're not. Let's connect at #HIMSS24 and discuss. #LTIGlobal #cybersecurity

There are two more days to register for your free place at our upcoming webinar. Here's a reminder of what it's all about: Our expert panel Simon Pannett, Jo Wallis, Helen Landels and Brad Groves will take a closer look at the European access environment for rare disease treatments and explore why Europe remains an attractive market. By attending this webinar, you will:   · Get an overview of the key differences and similarities between global and European access environments. What does that look like in terms of pre- and post-approval activity? · Gain insights into key considerations from an industry perspective: key challenges and opportunities in rare diseases. Critical points in terms of evidence generation, economic modelling and system engagement · Understand what a difference early engagement can have on your revenue optimisation across the whole lifecycle This session is particularly relevant for European product innovators, market access, pricing and reimbursement professionals who would like to unlock the opportunities available for revenue optimisation.   Click the link to register your free place now: https://lnkd.in/e3Df2t5k #events #webinar #marketaccess #europe

The four main Global Evidence Summit organising partners are joined by three host organisations, one co-sponsor, six program partners and an endorsing organisation, all committed to the #GES2024 theme, ‘Using evidence. Improving lives’. Learn more about these collaborative forces.👇 https://ow.ly/AvGv50RiFEB JBI, Cochrane, The Campbell Collaboration, Guidelines International Network, World Health Organization, American Institutes for Research, Institute of Development Studies, Centre for Evidence and Implementation

A great line up here for this webinar!

eHealth, mHealth, biosensing, wearables. A wealth of health-related data. But how will we integrate it so that we can truly capture ourselves in meaningful ways? In line with my research interests, I ponder on how microphysiological systems and organs-on-chips will make an impact here. Building digital twins of our organs-on-chips could provide invaluable lessons into capturing the form and function of relatively simple dynamic living systems in comprehensive computational models based on sensor data. Lessons that could then be applied to more complex living systems, including our own bodies. Interested? I would advise you to come and discuss with thought-leaders from EPFL (École polytechnique fédérale de Lausanne), University of Twente, ETH Zürich and imec at this 1st International Symposium on Digital Twins in Healthcare in Cyprus in May. #DigitalTwins #HealthcareInnovation #eHealth #mHealth #Biosensing #Wearables #OrgansOnChips #EPFL #UniversityOfTwente #ETHZurich #imec #OoC #organonachip #mps #microphysiological #biosensors

Step into the future of health with Dr. James Mault, Chief Executive Officer of BiolntelliSense and M42 Advisory Board member, as he underscores the profound impact of M42’s tech-driven disruption. Discover how innovative solutions are reshaping the healthcare ecosystem and establishing new clinical frontiers. Watch the full discussion on our YouTube channel - https://bit.ly/3XliEqf

"Exciting insights from Dr. James Mault on the future of healthcare! Discover how M42 Health 's cutting-edge technology is revolutionizing the industry. Check out the full discussion here: https://bit.ly/3XliEqf 🚀 #HealthTech #Innovation"

Catch our COO Kate Woolland together with a panel of experts for the final segment of IQVIA UK and Ireland 's “Making Market Access Real” series, focusing on accelerating innovation.   This week’s segment transitions from discussing the challenges behind the implementation of innovative solutions in healthcare to the crucial topic of cross-company adoption of innovation. The panel highlights the importance of bringing together different organizations and focusing on pathways, alongside products, to successfully introduce innovations into the NHS, concluding with top tips for innovators.   At Closed Loop Medicine, our mission is to provide a pathway for all individuals to access high-quality personalized treatment, by enabling real-time, real-world drug dose optimization of both new and established medicines – offering precision care for all whilst supporting healthcare providers and addressing the current shortfall in scalable personalized healthcare solutions.   Listen to the full discussion below 👇   #Healthcare #Innovation #NHS #PrecisionCare

💡 Check out the final segment of our 'Making Market Access Real' series focusing on Accelerating Innovation. Where our panel of experts Richard Stubbs, Chair of the National Health Innovation Network, Kate Woolland, Chief Operating Officer, Closed Loop Medicine, Jim McArdle, Strategy Lead, Patient Services, IQVIA and Paul Henderson, Director of Consulting, UK&I Healthcare & Government, IQVIA, dive into the crucial topic of cross-company adoption of innovation. Discover the importance of bringing together different organisations and focusing on pathways that align with your local healthcare system. Watch the video now!